We tested this idea in pancreatic tumor–bearing KPfC mice that harbored heterozygous loss of p53 and conditionally expressed mutant K-Ras (genotype Kraswt/LSL–G12D Tp53fl/+ PDX1-Cre+) (31, 32). The gene discussed is KRAS; the disease is pancreatic neoplasm.